Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
11 hedge funds and large institutions have $675K invested in Orgenesis Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 10 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.12% less ownership
Funds ownership: 3.29% → 3.18% (-0.12%)
28% less capital invested
Capital invested by funds: $932K → $675K (-$256K)
39% less funds holding
Funds holding: 18 → 11 (-7)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$66.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$64.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$27.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.39K |
| 5 |
Citigroup
New York
|
+$840 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$47.3K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$24.3K |
| 3 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$19K |
| 4 |
Renaissance Technologies
New York
|
-$17.7K |
| 5 |
RFN
Redwood Financial Network
Solon,
Ohio
|
-$15K |
ORGS Hedge Fund Activity: Q3 2024 in Review
11 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q3 2024, worth a combined $675K — down 28% from $932K a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ORGS and 3 opened new positions — a net loss of 7 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $66.7K. The largest seller was State Street, exiting entirely with an estimated $47.3K sold.
- 11 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q3 2024, down from 18 in Q2 2024.
- Funds reported $675K of Orgenesis Inc. Common Stock stock for Q3 2024, down 28% quarter-over-quarter.
- 3 funds opened new Orgenesis Inc. Common Stock positions in Q3 2024 and 10 closed out, a net change of -7 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q3 2024 was Osaic Holdings, an estimated $66.7K added.
- The largest Orgenesis Inc. Common Stock seller in Q3 2024 was State Street, an estimated $47.3K sold.
Based on aggregated 13F filings for Q3 2024.